No transfer of arousal from other's eyes in Williams syndrome.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 10 2023
Historique:
received: 16 08 2023
accepted: 20 10 2023
medline: 30 10 2023
pubmed: 27 10 2023
entrez: 26 10 2023
Statut: epublish

Résumé

Typically developing humans automatically synchronize their arousal levels, resulting in pupillary contagion, or spontaneous adaptation of pupil size to that of others. This phenomenon emerges in infancy and is believed to facilitate social interaction. Williams syndrome (WS) is a genetic condition characterized by a hyper-social personality and social interaction challenges. Pupillary contagion was examined in individuals with WS (n = 44), age-parallel-matched typically developing children and adults (n = 65), and infants (n = 79). Bayesian statistics were used. As a group, people with WS did not show pupillary contagion (Bayes factors supporting the null: 25-50) whereas control groups did. This suggests a very early emerging atypical developmental trajectory. In WS, higher pupillary contagion was associated with lower autistic symptoms of social communication. Diminished synchronization of arousal may explain why individuals with WS have social challenges, whereas synchronization of arousal is not a necessary correlate of high social motivation.

Identifiants

pubmed: 37884631
doi: 10.1038/s41598-023-45521-5
pii: 10.1038/s41598-023-45521-5
pmc: PMC10603144
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18397

Informations de copyright

© 2023. The Author(s).

Références

Nat Neurosci. 2016 Apr 26;19(6):647-655
pubmed: 29323671
Psychol Sci. 2016 Jul;27(7):997-1003
pubmed: 27207876
J Neurodev Disord. 2016 Dec 30;8:46
pubmed: 28050217
Neurosci Biobehav Rev. 2017 Sep;80:99-114
pubmed: 28506927
Nat Neurosci. 2005 Aug;8(8):991-3
pubmed: 16007084
Adv Exp Med Biol. 2017;1031:39-54
pubmed: 29214565
Sci Rep. 2017 Aug 29;7(1):9601
pubmed: 28851872
J Psychiatr Res. 2018 Feb;97:70-76
pubmed: 29202275
Biol Psychiatry. 2023 Jul 1;94(1):8-17
pubmed: 36639295
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Psychol Sci. 2015 Sep;26(9):1401-10
pubmed: 26231910
Sci Rep. 2018 Jan 9;8(1):127
pubmed: 29317675
Trends Cogn Sci. 2012 Apr;16(4):231-9
pubmed: 22425667
J Autism Dev Disord. 2008 May;38(5):806-14
pubmed: 17874179
J Autism Dev Disord. 2018 Sep;48(9):3037-3050
pubmed: 29671106
Soc Cogn Affect Neurosci. 2021 Jan 18;16(1-2):153-166
pubmed: 33002117
Sci Rep. 2018 Feb 26;8(1):3602
pubmed: 29483603
Neuropsychologia. 2008 Sep;46(11):2855-60
pubmed: 18561959
Curr Neurol Neurosci Rep. 2018 Oct 17;18(12):94
pubmed: 30328520
Neuropsychologia. 2006;44(2):254-9
pubmed: 16005478
Psychol Sci. 2019 Feb;30(2):309-315
pubmed: 30444671
Soc Cogn Affect Neurosci. 2006 Jun;1(1):5-17
pubmed: 17186063
Orphanet J Rare Dis. 2021 Nov 7;16(1):472
pubmed: 34743752
J Autism Dev Disord. 2023 Jul;53(7):2786-2797
pubmed: 35445369
J Dev Behav Pediatr. 2009 Aug;30(4):289-99
pubmed: 19668090
Res Dev Disabil. 2015 Oct-Nov;45-46:202-9
pubmed: 26263406
Res Dev Disabil. 2014 Aug;35(8):1838-49
pubmed: 24794322
Sci Rep. 2023 Jan 4;13(1):164
pubmed: 36599864
Neurosci Biobehav Rev. 2000 Aug;24(6):581-604
pubmed: 10940436
J Cogn. 2018 Feb 21;1(1):16
pubmed: 31517190
Front Psychol. 2019 Dec 10;10:2767
pubmed: 31920819
Trends Cogn Sci. 2009 Mar;13(3):127-34
pubmed: 19217822
Res Dev Disabil. 2020 May;100:103604
pubmed: 32142968
Front Psychol. 2012 Apr 17;3:111
pubmed: 22529829
Am J Intellect Dev Disabil. 2021 Jan 1;126(1):58-74
pubmed: 33370791
Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):E7265-E7274
pubmed: 30012623
Cogn Neuropsychiatry. 2009 Nov;14(6):510-23
pubmed: 19736593
J Cogn Neurosci. 2000;12 Suppl 1:30-46
pubmed: 10953232
J Autism Dev Disord. 2015 Aug;45(8):2594-612
pubmed: 25800866
Res Dev Disabil. 2020 Sep;104:103701
pubmed: 32554266
J Autism Dev Disord. 2009 Mar;39(3):421-31
pubmed: 18787936
Am J Intellect Dev Disabil. 2022 Jul 1;127(4):293-312
pubmed: 36122327
Res Dev Disabil. 2017 Dec;71:77-87
pubmed: 29032288
Cogn Emot. 2022 Aug;36(5):928-942
pubmed: 35536560
Front Psychol. 2018 Apr 05;9:463
pubmed: 29674990
Front Psychol. 2018 Aug 28;9:1587
pubmed: 30210410
J Autism Dev Disord. 2014 Oct;44(10):2400-12
pubmed: 23143131
PLoS One. 2017 Nov 28;12(11):e0188446
pubmed: 29182643
Psychon Bull Rev. 2007 Oct;14(5):779-804
pubmed: 18087943
Cogn Neuropsychiatry. 2010 Nov;15(6):505-30
pubmed: 20432078

Auteurs

Johan Lundin Kleberg (JL)

Department of Psychology, Stockholm University, Stockholm, Sweden. johan.lundin.kleberg@su.se.
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. johan.lundin.kleberg@su.se.

Astrid E Z Hallman (AEZ)

Department of Psychology, Stockholm University, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.

Martyna A Galazka (MA)

Department of Applied Information Technology, Division of Cognition and Communication, University of Gothenburg, Gothenburg, Sweden.

Deborah M Riby (DM)

Department of Psychology, Durham University, Durham, UK.

Sven Bölte (S)

Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
Child and Adolescent Psychiatry, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
Curtin Autism Research Group, Curtin School of Allied Health, Curtin University, Perth, WA, Australia.

Charlotte Willfors (C)

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.

Christine Fawcett (C)

Department of Psychology, Stockholm University, Stockholm, Sweden.
Department of Psychology, Uppsala University, Uppsala, Sweden.

Ann Nordgren (A)

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH